Filing Details
- Accession Number:
- 0001209191-17-031389
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-10 17:58:28
- Reporting Period:
- 2017-05-08
- Filing Date:
- 2017-05-10
- Accepted Time:
- 2017-05-10 17:58:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1625101 | Pulse Biosciences Inc. | PLSE | Surgical & Medical Instruments & Apparatus (3841) | 465696597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674555 | B. Thierry Thaure | 849 Mitten Road, Suite 104 Burlingame CA 94010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-08 | 15,000 | $2.67 | 15,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-08 | 15,000 | $22.49 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2017-05-08 | 15,000 | $0.00 | 15,000 | $2.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
60,655 | 2020-06-01 | No | 4 | M | Direct |
Footnotes
- This is the weighted average purchase price of the shares, which ranged from $22.00 to $23.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- The shares subject to the option will vest in equal quarterly installments over a three year period commencing on June 1, 2015 and ending on March 1, 2018, subject to the Reporting Person's continued service through each vesting date.